Clinical Trial Update: Safety and Tolerability of hRPC in Retinitis Pigmentosa [Phase 1, Phase 2]

View source ↗

Summary

Safety and tolerability data from early-phase trials of hRPC in retinitis pigmentosa are reported, with unknown overall-phase status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• hRPC (human retinal progenitor cell (hRPC))

Snippet

Sponsor: ReNeuron Limited | Conditions: Retinitis Pigmentosa | Phase 1, Phase 2 | Status: UNKNOWN